Copy number variation of the beta-defensin genes in Europeans: No supporting evidence for association with lung function, chronic obstructive pulmonary disease or asthma

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Wain, Louise V ^a   Odenthal Hesse, Linda ^a   Abujaber, Razan ^a   Sayers, Ian ^b   Beardsmore, Caroline ^a,c   Gaillard, Erol A ^a,c   Chappell, Sally ^d   Dogaru, Cristian M ^e   McKeever, Tricia ^d   Guetta Baranes, Tamar ^d   Kalsheker, Noor ^d   Kuehni, Claudia E ^e   Hall, Ian P ^b   Tobin, Martin D ^a,c   Hollox, Edward J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c GLENFIELD HOSPITAL   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BETA DEFENSIN GENE; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; DEFB103 GENE; DEFB104 GENE; DEFB4 GENE; DISEASE ASSOCIATION; ETHNIC GROUP; EUROPE; EUROPEAN; FEMALE; FUNCTIONAL ASSESSMENT; GENETIC ASSOCIATION; GENETIC RISK; HERITABILITY; HUMAN; INNATE IMMUNITY; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; SAMPLE SIZE; SMOKING; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BETA-DEFENSINS; CASE-CONTROL STUDIES; CHILD; DNA COPY NUMBER VARIATIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84896779634     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084192     Document Type: Article

References (53)

1. Myint PK, Luben RN, Surtees PG, Wainwright NW, Welch AA, et al. (2005) Respiratory function and self-reported functional health: EPIC-Norfolk population study. Eur Respir J 26: 494-502. (Pubitemid 41264215)
2. Schunemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M (2000) Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118: 656-664.
3. Strachan DP (1992) Ventilatory function, height, and mortality among lifelong non-smokers. J Epidemiol Community Health 46: 66-70.
4. Young RP, Hopkins R, Eaton TE (2007) Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 30: 616-622. (Pubitemid 351194819)
5. Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, et al. (2010) Metaanalyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 42: 45-52.
6. Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, et al. (2010) Genome-wide association study identifies five loci associated with lung function. Nat Genet 42: 36-44.
7. Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, et al. (2011) Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 43: 1082-1090.
8. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, et al. (2006) Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 27: 397-412. (Pubitemid 43180921)
9. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, et al. (1998) Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 157: 1770-1778.
10. Castaldi PJ, Cho MH, Litonjua AA, Bakke P, Gulsvik A, et al. (2011) The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol 45: 1147-1153.
11. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, et al. (2010) Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 42: 200-202.
12. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, et al. (2009) A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 5: e1000421.
13. Soler Artigas M, Wain LV, Repapi E, Obeidat M, Sayers I, et al. (2011) Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med 184: 786-795.
14. Wilk JB, Shrine NR, Loehr LR, Zhao JH, Manichaikul A, et al. (2012) Genomewide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 186: 622-632.
15. Braman SS (2006) The global burden of asthma. Chest 130: 4S-12S. (Pubitemid 44107231)
16. Himes BE, Hunninghake GM, Baurley JW, Rafaels NM, Sleiman P, et al. (2009) Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet 84: 581-593.
17. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, et al. (2010) A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363: 1211-1221.
18. Wan YI, Shrine NR, Soler Artigas M, Wain LV, Blakey JD, et al. (2012) Genome-wide association study to identify genetic determinants of severe asthma. Thorax 67: 762-768.
19. Myers RA, Himes BE, Gignoux CR, Yang JJ, Gauderman WJ, et al. (2012) Further replication studies of the EVE Consortium meta-analysis identifies 2 asthma risk loci in European Americans. J Allergy Clin Immunol 130: 1294-1301.
20. Cookson WO, Moffatt MF (2011) Genetics of complex airway disease. Proc Am Thorac Soc 8: 149-153.
21. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, et al. (2010) Origins and functional impact of copy number variation in the human genome. Nature 464: 704-712.
22. Semple F, Dorin JR (2012) beta-Defensins: multifunctional modulators of infection, inflammation and more? J Innate Immun 4: 337-348.
23. Bals R, Wang X, Wu Z, Freeman T, Bafna V, et al. (1998) Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102: 874-880. (Pubitemid 28419232)
24. Ishimoto H, Mukae H, Date Y, Shimbara T, Mondal MS, et al. (2006) Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia. Eur Respir J 27: 253-260. (Pubitemid 43180899)
25. Tecle T, Tripathi S, Hartshorn KL (2010) Review: Defensins and cathelicidins in lung immunity. Innate Immun 16: 151-159.
26. Yanagi S, Ashitani J, Ishimoto H, Date Y, Mukae H, et al. (2005) Isolation of human beta-defensin-4 in lung tissue and its increase in lower respiratory tract infection. Respir Res 6: 130.
27. Moranta D, Regueiro V, March C, Llobet E, Margareto J, et al. (2010) Klebsiella pneumoniae capsule polysaccharide impedes the expression of betadefensins by airway epithelial cells. Infect Immun 78: 1135-1146.
28. Tsutsumi-Ishii Y, Nagaoka I (2003) Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J Immunol 170: 4226-4236. (Pubitemid 36428189)
29. Fode P, Jespersgaard C, Hardwick RJ, Bogle H, Theisen M, et al. (2011) Determination of beta-defensin genomic copy number in different populations: a comparison of three methods. PLoS One 6: e16768.
30. Hardwick RJ, Machado LR, Zuccherato LW, Antolinos S, Xue Y, et al. (2011) A worldwide analysis of beta-defensin copy number variation suggests recent selection of a high-expressing DEFB103 gene copy in East Asia. Hum Mutat 32: 743-750.
31. Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, et al. (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40: 23-25.
32. Stuart PE, Huffmeier U, Nair RP, Palla R, Tejasvi T, et al. (2012) Association of beta-defensin copy number and psoriasis in three cohorts of European origin. J Invest Dermatol 132: 2407-2413.
33. Bentley RW, Pearson J, Gearry RB, Barclay ML, McKinney C, et al. (2010) Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol 105: 354-359.
34. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, et al. (2006) A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79: 439-448. (Pubitemid 44384253)
35. Hardwick RJ, Amogne W, Mugusi S, Yimer G, Ngaimisi E, et al. (2012) betadefensin genomic copy number is associated with HIV load and immune reconstitution in sub-saharan Africans. J Infect Dis 206: 1012-1019.
36. Hollox EJ (2010) Beta-defensins and Crohn's disease: confusion from counting copies. Am J Gastroenterol 105: 360-362.
37. Britton JR, Pavord ID, Richards KA, Knox AJ, Wisniewski AF, et al. (1995) Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 151: 1383-1387.
38. McKeever TM, Scrivener S, Broadfield E, Jones Z, Britton J, et al. (2002) Prospective study of diet and decline in lung function in a general population. Am J Respir Crit Care Med 165: 1299-1303. (Pubitemid 34461744)
39. Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2006) Global Strategy for the Diagnosis, Management and Prevention of COPD.
40. Hankinson JL, Crapo RO, Jensen RL (2003) Spirometric reference values for the 6-s FVC maneuver. Chest 124: 1805-1811. (Pubitemid 37433576)
41. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, et al. (2010) Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study. Chest 137: 138-145.
42. Kuehni CE, Brooke AM, Strippoli MP, Spycher BD, Davis A, et al. (2007) Cohort profile: the Leicester respiratory cohorts. Int J Epidemiol 36: 977-985. (Pubitemid 350019237)
43. Dogaru CM, Strippoli MP, Spycher BD, Frey U, Beardsmore CS, et al. (2012) Breastfeeding and lung function at school age: does maternal asthma modify the effect? Am J Respir Crit Care Med 185: 874-880.
44. Strippoli MP, Kuehni CE, Dogaru CM, Spycher BD, McNally T, et al. (2013) Etiology of Ethnic Differences in Childhood Spirometry. Pediatrics.
45. Chappell S, Daly L, Morgan K, Guetta Baranes T, Roca J, et al. (2006) Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat 27: 103-109. (Pubitemid 43042972)
46. Aldhous MC, Abu Bakar S, Prescott NJ, Palla R, Soo K, et al. (2010) Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease. Hum Mol Genet 19: 4930-4938.
47. Hollox EJ, Armour JA, Barber JC (2003) Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 73: 591-600. (Pubitemid 37076271)
48. Andresen E, Gunther G, Bullwinkel J, Lange C, Heine H (2011) Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease. PLoS One 6: e21898.
49. Liao Z, Dong J, Hu X, Wang T, Wan C, et al. (2012) Enhanced expression of human beta-defensin 2 in peripheral lungs of patients with chronic obstructive pulmonary disease. Peptides 38: 350-356.
50. Levy H, Raby BA, Lake S, Tantisira KG, Kwiatkowski D, et al. (2005) Association of defensin beta-1 gene polymorphisms with asthma. J Allergy Clin Immunol 115: 252-258. (Pubitemid 40215086)
51. Janssens W, Nuytten H, Dupont LJ, Van Eldere J, Vermeire S, et al. (2010) Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182: 163-169.
52. Abu Bakar S, Hollox EJ, Armour JA (2009) Allelic recombination between distinct genomic locations generates copy number diversity in human betadefensins. Proc Natl Acad Sci U S A 106: 853-858.
53. Wain LV, Armour JA, Tobin MD (2009) Genomic copy number variation, human health, and disease. Lancet 374: 340-350.